Navigation Links
Cargill Receives Official Notification From FDA Supporting the Safety of Truvia(TM) Rebiana
Date:12/17/2008

New Natural Sweetener - Truvia(TM) Rebiana - Market Leader in New Sweetness Category

WAYZATA, Minn., Dec. 17 /PRNewswire/ -- Today, Cargill received official notification from the U.S. Food and Drug Administration (FDA) stating that the agency has no objection to the conclusion of an independent expert panel which reviewed research that rebaudioside A (rebiana), the identity in Truvia(TM) rebiana, is generally recognized as safe (GRAS) for use as a general purpose sweetener. The FDA letter affirms and supports rebiana's safety and the data used to make that determination.

"Given the extensive research conducted to assure the safety of Truvia(TM) rebiana, Cargill has tremendous confidence in the product. The FDA letter further validates what the science has concluded - that Truvia(TM) rebiana is safe for use for all consumers," said Marcelo Montero, president, Cargill Health & Nutrition. "The FDA brought the appropriate rigor to the process and we are extremely pleased with the news."

Truvia(TM) rebiana is a well-characterized, high-purity ingredient derived from the best tasting part of the stevia leaf. Cargill has spent the past five years developing the product to its specifications and working to produce the ingredient on a commercial scale. The high-purity ingredient - Truvia(TM) rebiana - is consistent in quality and composition. The FDA letter and the safety studies for Truvia(TM) rebiana pertain to only the high-purity products that meet the established criteria and not to all stevia.

In June 2008, the Joint FAO/WHO Expert Committee on Food Additives (JECFA) conducted a multi-year review of all the available scientific and clinical data on high purity steviol glycosides, including rebiana. In July 2008, the Committee determined that high purity, food-grade rebiana is safe for its intended use as a general-purpose sweetener, and established a perm
'/>"/>

SOURCE Cargill
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. E. Coli Registry Expanded for Victims of E. Coli Poisoning from Cargill Ground Beef
2. Volunteer for National Suicide Prevention Agency Earns Cargill Award
3. Cargill Executive Joins Blue Cross Board of Trustees
4. ChromaDex Partners With Cargill to Provide Global Quality Control Methods and Standards for Sweet Components of Stevia
5. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
6. DaVita Receives Civil Complaint
7. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
8. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
9. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
10. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
11. UT Southwesterns obesity research receives $22 million NIH Roadmap grant

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Tomorrow may be too late when it c...on, according to TOPS Club, Inc. (Take Off Pounds ...ization. , (Vocus) Novemb...es to preventing or improving a diabetes condition...nsibly), the nonprofit weight-loss support organiz...
(Date:11/9/2009)...National Comprehensive Cancer Network (NCCN) has p...details a draft paradigm for near-term comparative...sting data. The document introduces the NCCN Compa...sed process that compares the risk-versus-benefit ...NCCN Clinical Practice Guidelines in Oncology(TM)....
(Date:11/9/2009)...rch of Dimes Names 2010 National Ambassador ,...e/ -- Joshua Hoffman of Weston, Fla., was born so ...doctors could not say whether he would survive -- ..., the 6-year-old was named March of Dimes 2010 Nat...fman, recalls, "My first minutes of motherhood and...
(Date:11/9/2009)...YORK, Nov. 9 The award-w...s world television debut on the Sundance Channel o...T/PST. ,, Directed by Academy Award® nomi...of children with type 1 diabetes amid the verdant ...orld,s poorest countries. The children are support...
(Date:11/9/2009)...YORK, Nov. 9 /PRNewswire/ -- Phoenix House , ...buse treatment and prevention program, announced t...onally and internationally recognized leader in su...nical Officer, effective January 1, 2010. ,, ...ance abuse treatment research and her work has res...
Breaking Medicine News(10 mins):Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 2Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 4Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 5Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 6Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3
...Practice Pulse Report Released Today , , SOUTH BE...rment has spurred improvements at medical practice...ching upwards as a result, according to a new repo...consumer-driven health care in which patients are ...
...arch 1 Nelnet, Inc. (NYSE: NNI ),announced toda...-end results,as the company,s independent external...the company,s derivative portfolio, which is exclu...ming of the,completion of the review, the company ...
...ded its Line of Credit until August 2010. , , - A... flat with the third quarter of 2008 and down from...cupancy for the full year was 89.6% compared to 90...f 2007, and $3,791 for the full year of 2008, a 6....
...the body, dendritic cells act as the security alar...e of intruders, dendritic cells can transmit the a...epending on the signals they send out. , Researc...rough two different receptors, by sending out both...
..., parents are urged to take steps early to prevent...ws) -- Overweight children, teenagers and adults a...se days. The trend toward bigger and bigger babies... babies born 20 years ago, a recent study found. ,...
... MakroCare, a global clinical services firm, o...PRWEB) March 1, 2009 -- MakroCare, US based multid... clinical services firm, which provides clinical r...To meet the growing needs and serve its clients in...
Other Medicine News:Health News:Medical Practices Improving Service, Consumer Satisfaction Rises 2Health News:Medical Practices Improving Service, Consumer Satisfaction Rises 3Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 2Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 3Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 4Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 5Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 6Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 7Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 8Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 9Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 10Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 11Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 12Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 13Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 14Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 15Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 16Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 17Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 18Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 19Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 20Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 21Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 22Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 23Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 24Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 25Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 26Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 27Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 28Health News:Brookdale Announces Fourth Quarter and Full Year 2008 Results 29Health News:Vitamin A signals offer clues to treating autoimmunity 2Health News:Undoing the 'Big Baby' Trend 2Health News:Undoing the 'Big Baby' Trend 3
(Date:11/9/2009)...,, BOSTON, Nov. 9 PAR... leading global biopharmaceutical services provide...c safety capabilities for early phase clinical dev...nt, Inc., which manufactures and distributes elect...worldwide. PAREXEL is using Mortara Instrument,s S...
(Date:11/8/2009)...,, AARP Praises House Passage of Health Care R...ngthen Medicare, improve coverage for all American...wire/ -- Today the United States House of Represen...tion that would strengthen Medicare for seniors an...rices millions of Americans out of affordable heal...
(Date:11/6/2009)...,, BOTHELL, Wash., Nov. 6 /PRNewswire-FirstCall...ed financial results for the three and nine months...er, SCOLR Pharma,s President and CEO, said, "We co... our 12-hour ibuprofen formulation. Several potent...in time, personnel and external resources as they ...
Breaking Medicine Technology:PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 2PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 3PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 4PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 5AARP Idaho Key Vote News Alert 2AARP Idaho Key Vote News Alert 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9Food Industry 3A Carbonostics Responds To Sustainability Obstacles 59867 1Food Industry 3A Carbonostics Responds To Sustainability Obstacles 59867 2Food Industry 3A Carbonostics Responds To Sustainability Obstacles 59867 3Food Industry 3A Carbonostics Responds To Sustainability Obstacles 59867 4Abbott Completes Visiogen Acquisition 5625 1Abbott Completes Visiogen Acquisition 5625 2AlphaDetail Tracking Study Enhancements 3A The Advantage of Integration and Speed 5621 1AlphaDetail Tracking Study Enhancements 3A The Advantage of Integration and Speed 5621 2
...-(BUSINESS WIRE)--May 21, 2007 - Cougar Biotechnol...ve Phase I and Phase,II data on the Company,s pros...tate) was presented at the American Urological,Ass...taking place,in Anaheim, California. The data was ...search UK Centre for Cancer Therapeutics at,The In...
...f BENICAR HCT 40/12.5 and 40/25 mg/day and Amlodip...t American Society of,Hypertension Twenty-Second A..., 2007 /PRNewswire/ -- New data,presented today at...ond Annual Scientific Meeting (ASH 2007) in Chicag...icar HCT,(olmesartan medoxomil/hydrochlorothiazide...
Other Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 2Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 3Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 5Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 6Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 7Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 8
MultiWash Advantage
Synchron
...y method for HbA1c provides outstanding accuracy a...ment with the HPLC method(1) , Near-patient resu...ults are reliable(2) , National Glycohemoglobin ...s recommended by the ADA** , , , Microalbum...
Blood Coagulation Analyzer CG Series
Medicine Products: